MA23832A1 - Derives d'acide hydroxamique nouveaux, procede pour leur production et compositions les contenant - Google Patents

Derives d'acide hydroxamique nouveaux, procede pour leur production et compositions les contenant

Info

Publication number: MA23832A1
Authority: MA; Morocco
Prior art keywords: production; compositions containing; acid derivatives; hydroxamic acid; novel hydroxamic
Prior art date: 1995-03-31

Application number

MA24191A

Other languages

English (en)

Inventor

Ito Fumitaka

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-31

Filing date

1996-03-25

Publication date

1996-10-01

1996-03-25 Application filed by Pfizer filed Critical Pfizer

1996-10-01 Publication of MA23832A1 publication Critical patent/MA23832A1/fr

Links

NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Furan Compounds (AREA)

MA24191A 1995-03-31 1996-03-25 Derives d'acide hydroxamique nouveaux, procede pour leur production et compositions les contenant MA23832A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP9500631		1995-03-31

Publications (1)

Publication Number	Publication Date
MA23832A1 true MA23832A1 (fr)	1996-10-01

Family

ID=14125824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24191A MA23832A1 (fr)	1995-03-31	1996-03-25	Derives d'acide hydroxamique nouveaux, procede pour leur production et compositions les contenant

Country Status (35)

Country	Link
US (2)	US5952369A (fr)
EP (1)	EP0817772B1 (fr)
JP (1)	JP3035356B2 (fr)
KR (1)	KR100258657B1 (fr)
AP (1)	AP625A (fr)
AR (1)	AR002729A1 (fr)
AT (1)	ATE231840T1 (fr)
AU (1)	AU693336B2 (fr)
BG (1)	BG62611B1 (fr)
BR (1)	BR9607750A (fr)
CA (1)	CA2213815C (fr)
CZ (1)	CZ306497A3 (fr)
DE (1)	DE69626009T2 (fr)
DK (1)	DK0817772T3 (fr)
ES (1)	ES2188743T3 (fr)
HR (1)	HRP960141A2 (fr)
HU (1)	HUP9900767A3 (fr)
IL (2)	IL117440A0 (fr)
IS (1)	IS4547A (fr)
LV (1)	LV11971B (fr)
MA (1)	MA23832A1 (fr)
NO (1)	NO974513D0 (fr)
NZ (1)	NZ304113A (fr)
OA (1)	OA10518A (fr)
PE (1)	PE43397A1 (fr)
PL (1)	PL322652A1 (fr)
RU (1)	RU2144917C1 (fr)
SI (1)	SI9620039A (fr)
SK (1)	SK129897A3 (fr)
TN (1)	TNSN96045A1 (fr)
TR (1)	TR199701082T1 (fr)
TW (1)	TW408111B (fr)
WO (1)	WO1996030339A1 (fr)
YU (1)	YU18696A (fr)
ZA (1)	ZA962476B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9701042A (es) *	1996-02-07	1998-05-31	Pfizer	Compuestos del acido hidroxamico.
TNSN97092A1 (ar)	1996-09-18	1999-12-31	Agouron Pharma	مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.
WO1998024431A1 (fr) *	1996-12-02	1998-06-11	Kyorin Pharmaceutical Co., Ltd.	Nouveaux derives de pyrrolidine n-substitues et procede de preparation de ces derives
JP2000507970A (ja) *	1997-01-10	2000-06-27	メルクエンドカンパニーインコーポレーテッド	キラルメディエータの効率的な合成
EP0982297A3 (fr) *	1998-08-24	2001-08-01	Pfizer Products Inc.	Procédé de préparation de dérivés de acide hydroxamique substitués par hydroxy-pyrrolidinyl, qui sont agonistes du récepteur opioid kappa
KR100295740B1 (ko) *	1998-09-17	2001-11-05	박영구	N-치환된-하이드록시고리화알킬아민유도체의제조방법
US6444829B1 (en) *	2000-07-19	2002-09-03	Hoffmann-La Roche Inc.	Pyrrolidine compounds
AU2002247886A1 (en)	2001-04-30	2002-11-11	Pfizer Products Inc.	Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists
US7091357B2 (en) *	2001-12-26	2006-08-15	University Of Kentucky Research Foundation	Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies
GB0202873D0 (en) *	2002-02-07	2002-03-27	Novartis Ag	Organic compounds
WO2004039785A1 (fr) *	2002-11-01	2004-05-13	Pfizer Products Inc.	Procede servant a preparer des composes de pyrolidinyle ethylamine par l'intermediaire d'une arylamination provoquee par du cuivre
JP2006523670A (ja) *	2003-04-14	2006-10-19	ワーナー−ランバートカンパニーリミティドライアビリティーカンパニー	５−（４−フルオロフェニル）−１−［２−（（２ｒ，４ｒ）−４−ヒドロキシ−６−オキソ−テトラヒドロ−ピラン−２−イル）エチル］−２−イソプロピル−４−フェニル−１ｈ−ピロール−３−カルボン酸フェニルアミドの調製方法
UA89035C2 (ru) *	2003-12-03	2009-12-25	Лео Фарма А/С	Эфиры гидроксамовых кислот и их фармацевтическое применение
GB0821010D0 (en) *	2008-11-17	2008-12-24	Univ Warwick	Plant development control composition
JP6254075B2 (ja)	2011-05-16	2017-12-27	バイオノミックスリミテッド	カリウムチャネル遮断剤としてのアミン誘導体
JP6138169B2 (ja) *	2012-03-05	2017-05-31	ドクターレディズラボラトリーズリミテッド	κオピオイド受容体（ＫＯＲ）アゴニストとしての置換複素環式アセトアミド
GB201210395D0 (en) *	2012-06-11	2012-07-25	Syngenta Participations Ag	Crop enhancement compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3268539A (en) *	1963-05-20	1966-08-23	Universal Oil Prod Co	Tertiary-aminoalkyl derivatives of diaryl substituted acetohydroxamic acid esters

1996
- 1996-03-11 IL IL11744096A patent/IL117440A0/xx unknown
- 1996-03-14 AP APAP/P/1996/000791A patent/AP625A/en active
- 1996-03-15 TW TW085103136A patent/TW408111B/zh active
- 1996-03-25 MA MA24191A patent/MA23832A1/fr unknown
- 1996-03-25 PE PE1996000208A patent/PE43397A1/es not_active Application Discontinuation
- 1996-03-26 HR HRPCT/JP95/631A patent/HRP960141A2/hr not_active Application Discontinuation
- 1996-03-27 YU YU18696A patent/YU18696A/sh unknown
- 1996-03-28 US US08/913,823 patent/US5952369A/en not_active Expired - Fee Related
- 1996-03-28 SI SI9620039A patent/SI9620039A/sl not_active IP Right Cessation
- 1996-03-28 SK SK1298-97A patent/SK129897A3/sk unknown
- 1996-03-28 BR BR9607750A patent/BR9607750A/pt active Search and Examination
- 1996-03-28 AT AT96907686T patent/ATE231840T1/de not_active IP Right Cessation
- 1996-03-28 HU HU9900767A patent/HUP9900767A3/hu unknown
- 1996-03-28 NZ NZ304113A patent/NZ304113A/xx unknown
- 1996-03-28 DE DE69626009T patent/DE69626009T2/de not_active Expired - Fee Related
- 1996-03-28 PL PL96322652A patent/PL322652A1/xx unknown
- 1996-03-28 AU AU51211/96A patent/AU693336B2/en not_active Ceased
- 1996-03-28 ZA ZA9602476A patent/ZA962476B/xx unknown
- 1996-03-28 TR TR97/01082T patent/TR199701082T1/xx unknown
- 1996-03-28 CA CA002213815A patent/CA2213815C/fr not_active Expired - Fee Related
- 1996-03-28 ES ES96907686T patent/ES2188743T3/es not_active Expired - Lifetime
- 1996-03-28 WO PCT/JP1996/000820 patent/WO1996030339A1/fr not_active Ceased
- 1996-03-28 KR KR1019970706880A patent/KR100258657B1/ko not_active Expired - Fee Related
- 1996-03-28 EP EP96907686A patent/EP0817772B1/fr not_active Expired - Lifetime
- 1996-03-28 DK DK96907686T patent/DK0817772T3/da active
- 1996-03-28 RU RU97117590A patent/RU2144917C1/ru active
- 1996-03-28 JP JP08529174A patent/JP3035356B2/ja not_active Expired - Fee Related
- 1996-03-28 CZ CZ973064A patent/CZ306497A3/cs unknown
- 1996-03-29 TN TNTNSN96045A patent/TNSN96045A1/fr unknown
- 1996-03-29 AR ARP960101993A patent/AR002729A1/es unknown
1997
- 1997-08-19 IS IS4547A patent/IS4547A/is unknown
- 1997-09-17 BG BG101896A patent/BG62611B1/bg unknown
- 1997-09-29 NO NO974513A patent/NO974513D0/no not_active Application Discontinuation
- 1997-09-30 OA OA70091A patent/OA10518A/en unknown
- 1997-10-21 LV LVP-97-203A patent/LV11971B/en unknown
1999
- 1999-04-15 IL IL12947999A patent/IL129479A0/xx unknown
- 1999-04-29 US US09/302,097 patent/US6110947A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR9607750A (pt)	1998-06-30
LV11971B (en)	1998-06-20
AU693336B2 (en)	1998-06-25
DE69626009D1 (de)	2003-03-06
ZA962476B (en)	1997-09-29
YU18696A (sh)	1999-06-15
IL129479A0 (en)	2000-02-29
HUP9900767A2 (hu)	1999-07-28
RU2144917C1 (ru)	2000-01-27
LV11971A (lv)	1998-02-20
BG101896A (en)	1999-01-29
PL322652A1 (en)	1998-02-16
CZ306497A3 (cs)	1998-07-15
BG62611B1 (bg)	2000-03-31
IS4547A (is)	1997-08-19
PE43397A1 (es)	1997-10-13
AR002729A1 (es)	1998-04-29
KR100258657B1 (ko)	2000-07-01
TNSN96045A1 (fr)	2005-03-15
US5952369A (en)	1999-09-14
SI9620039A (sl)	1998-08-31
KR19980703476A (ko)	1998-11-05
HUP9900767A3 (en)	2001-01-29
AP9600791A0 (en)	1996-04-30
EP0817772B1 (fr)	2003-01-29
US6110947A (en)	2000-08-29
TR199701082T1 (xx)	1998-02-21
NO974513L (no)	1997-09-29
CA2213815A1 (fr)	1996-10-03
EP0817772A1 (fr)	1998-01-14
AP625A (en)	1997-12-24
ATE231840T1 (de)	2003-02-15
WO1996030339A1 (fr)	1996-10-03
OA10518A (en)	2002-04-22
JPH11501048A (ja)	1999-01-26
JP3035356B2 (ja)	2000-04-24
TW408111B (en)	2000-10-11
ES2188743T3 (es)	2003-07-01
AU5121196A (en)	1996-10-16
SK129897A3 (en)	1998-11-04
DE69626009T2 (de)	2003-08-14
DK0817772T3 (da)	2003-05-19
HRP960141A2 (en)	1997-10-31
NO974513D0 (no)	1997-09-29
MX9707454A (es)	1998-07-31
CA2213815C (fr)	2001-12-18
IL117440A0 (en)	1996-07-23
NZ304113A (en)	1999-01-28

Publication	Publication Date	Title
MA26675A1 (fr)	2004-12-20	Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24469A1 (fr)	1998-10-01	Derives d'acide arylsulfonyhydroxamique, procede pour leur preparation et compositions les contenant
MA26620A1 (fr)	2004-12-20	Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26571A1 (fr)	2004-12-20	Derives d'acide hydroxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
MA26638A1 (fr)	2004-12-20	Derives d'isothiazole nouveaux, procede pour leur preparation et compoositions pharmaceutiques les contenant
MA26439A1 (fr)	2004-12-20	Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA24340A1 (fr)	1998-07-01	Procede de production de derives nouveaux d'aminophosphates, et de compositions pharmaceutiques les contenant
MA24832A1 (fr)	1999-12-31	Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydropyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
FR2569402B1 (fr)	1989-09-22	Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2742148B1 (fr)	1999-10-22	Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr)	1997-04-18	Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
FR2777891B1 (fr)	2003-01-31	Derives d'aminoacides et procede pour leur production
MA23866A1 (fr)	1996-12-31	N-(indole-2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant
FR2567131B1 (fr)	1991-06-07	Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
PT78340A (fr)	1984-04-01	Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
BE880584A (fr)	1980-06-12	Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
MA26588A1 (fr)	2004-12-20	Derives d'erythromycine nouveaux, procede et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant
MA26603A1 (fr)	2004-12-20	Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26552A1 (fr)	2004-12-20	Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2738245B1 (fr)	1997-11-21	Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
FR2556343B1 (fr)	1988-03-04	Nouveaux derives d'aminoguanidine, procede pour leur preparation et medicaments les contenant
FR2605004B1 (fr)	1989-01-13	Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
MA26583A1 (fr)	2004-12-20	Derives de benzamide nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant